| Particulars (Rupees in Crores.) | Mar-2025 | Dec-2024 | Sept-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
Gross Sales | 8,506 | 8,358.6 | 8,016.1 | 7,672.7 | 7,083 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8,506 | 8,358.6 | 8,016.1 | 7,672.7 | 7,083 |
Other Operating Income | 22.4 | 22.6 | 22.1 | 23.4 | 30.8 |
Other Income | 527.6 | 154.4 | 313.6 | 193.1 | 201 |
Total Income | 9,056 | 8,535.6 | 8,351.8 | 7,889.2 | 7,314.8 |
Total Expenditure | 6,530.5 | 6,108.2 | 5,961.7 | 5,566.2 | 5,282.6 |
PBIDT | 2,525.5 | 2,427.4 | 2,390.1 | 2,323 | 2,032.2 |
Interest | 65.6 | 81.7 | 75.7 | 59.8 | 59.3 |
PBDT | 2,459.9 | 2,345.7 | 2,314.4 | 2,263.2 | 1,972.9 |
Depreciation | 454.7 | 471.4 | 397 | 380.6 | 367.7 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 432.3 | 533 | 771.3 | 521.5 | 282.3 |
Deferred Tax | -13.8 | -62.9 | -195.8 | -31.3 | 13.1 |
Reported Profit After Tax | 1,586.7 | 1,404.2 | 1,341.9 | 1,392.4 | 1,309.8 |
Minority Interest After NP | -6.6 | -9.5 | 86.2 | 0 | 0 |
Net Profit after Minority Interest | 1,593.3 | 1,413.7 | 1,255.7 | 1,392.4 | 1,309.8 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 1,593.3 | 1,413.7 | 1,255.7 | 1,392.4 | 1,309.8 |
EPS (Unit Curr.) | 19.12 | 16.97 | 75.4 | 83.61 | 78.66 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 83.4 | 83.4 | 83.4 | 83.4 | 83.4 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 29.69 | 29.04 | 29.81 | 30.27 | 28.69 |
PBDTM(%) | 28.91 | 28.06 | 28.87 | 29.49 | 27.85 |
PATM(%) | 18.65 | 16.79 | 16.74 | 18.14 | 18.49 |
Issuance of a Form 483 occurs when an investigator(s) has observed any conditions that in their judgment may constitute violations of the FD&C Act and related Acts.
The board has recommended a final dividend of ₹8 per equity share for FY 2024–25
Here are some of the stocks that may see significant price movement today: Adani Power, Dr Reddy's, and Bank of India, etc.
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.
Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.
Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
